| Name | LSP-249 |
|---|
| Description | LSP-249 (example 35), extracted from patent WO2016011209A1, is a plasma kallikrein inhibitor under the study for angioedema, with an EC50 less than 100 nM in cell[1]. |
|---|---|
| Related Catalog | |
| Target |
EC50:< 100 nM (kallikrein in cell)[1]. |
| References |
[1]. Andrew Mcdonald, et al. Therapeutic inhibitory compounds. Patent. WO2016011209A1. |
| Molecular Formula | C24H22ClN5O |
|---|---|
| Molecular Weight | 431.92 |
| Storage condition | -20°C |